Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,480 | 184 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $740.36 | 32 | $0 (2024) |
| ABBVIE INC. | $585.05 | 42 | $0 (2024) |
| GlaxoSmithKline, LLC. | $426.75 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $249.31 | 10 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $159.19 | 9 | $0 (2023) |
| Inspire Medical Systems, Inc. | $141.33 | 2 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $123.44 | 8 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $113.70 | 7 | $0 (2024) |
| Exact Sciences Corporation | $93.22 | 4 | $0 (2024) |
| Allergan, Inc. | $87.63 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $725.08 | 27 | AstraZeneca Pharmaceuticals LP ($211.47) |
| 2023 | $500.15 | 31 | ABBVIE INC. ($186.45) |
| 2022 | $897.48 | 47 | Novo Nordisk Inc ($317.81) |
| 2021 | $496.66 | 34 | AbbVie Inc. ($129.86) |
| 2020 | $406.88 | 19 | Novo Nordisk Inc ($201.77) |
| 2019 | $283.14 | 13 | GlaxoSmithKline, LLC. ($207.79) |
| 2018 | $67.81 | 5 | Novo Nordisk Inc ($25.68) |
| 2017 | $102.56 | 8 | AstraZeneca Pharmaceuticals LP ($25.33) |
All Payment Transactions
184 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Gastroenterology | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: VACCINES | ||||||
| 11/14/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: Oncology | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: PSYCHIATRY | ||||||
| 09/16/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: VACCINES | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Respiratory | ||||||
| 08/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: Oncology | ||||||
| 08/14/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: DERMATOLOGY | ||||||
| 07/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.42 | General |
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug), FARXIGA | Food and Beverage | In-kind items and services | $44.79 | General |
| Category: Respiratory | ||||||
| 06/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Respiratory | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $73.33 | General |
| Category: Respiratory | ||||||
| 06/04/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Central Nervous System | ||||||
| 06/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Respiratory | ||||||
| 05/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Respiratory | ||||||
| 05/07/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $28.52 | General |
| Category: Diagnostics | ||||||
| 04/24/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $46.19 | General |
| Category: NEUROLOGY | ||||||
| 04/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: RESPIRATORY | ||||||
| 04/11/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.21 | General |
| 03/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: RESPIRATORY | ||||||
| 03/01/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $95.14 | General |
| Category: NEUROLOGY | ||||||
| 02/28/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,212 | 1,686 | $234,585 | $100,315 |
| 2022 | 22 | 1,189 | 1,665 | $241,395 | $103,938 |
| 2021 | 27 | 1,550 | 2,252 | $295,329 | $133,978 |
| 2020 | 19 | 1,200 | 1,855 | $247,795 | $96,465 |
All Medicare Procedures & Services
92 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 213 | 348 | $62,640 | $27,027 | 43.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 221 | 221 | $55,250 | $25,823 | 46.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 222 | 481 | $55,632 | $25,651 | 46.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 26 | 33 | $12,375 | $6,637 | 53.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 26 | 27 | $9,450 | $3,830 | 40.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 28 | 28 | $2,800 | $1,895 | 67.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $3,640 | $1,034 | 28.4% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 52 | 52 | $2,600 | $875.68 | 33.7% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2023 | 54 | 54 | $2,700 | $842.40 | 31.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 22 | 25 | $3,601 | $821.04 | 22.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,400 | $819.00 | 34.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 59 | 81 | $3,122 | $768.63 | 24.6% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 11 | 26 | $2,600 | $762.32 | 29.3% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 30 | 30 | $2,250 | $718.20 | 31.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 38 | 38 | $1,900 | $639.92 | 33.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 18 | 18 | $693.72 | $511.92 | 73.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 16 | 16 | $800.00 | $350.40 | 43.8% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 11 | 13 | $1,430 | $340.81 | 23.8% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 13 | 13 | $1,300 | $307.45 | 23.7% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 28 | 32 | $3,840 | $279.42 | 7.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 51 | 73 | $1,387 | $245.52 | 17.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $864.00 | $114.85 | 13.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 22 | 23 | $460.00 | $13.72 | 3.0% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 14 | 17 | $850.00 | $6.57 | 0.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 229 | 493 | $57,020 | $27,512 | 48.3% |
About Dr. Robert Jantz, M.D
Dr. Robert Jantz, M.D is a Family Medicine healthcare provider based in Lebanon, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396751749.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Jantz, M.D has received a total of $3,480 in payments from pharmaceutical and medical device companies, with $725.08 received in 2024. These payments were reported across 184 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($3,480).
As a Medicare-enrolled provider, Jantz has provided services to 5,151 Medicare beneficiaries, totaling 7,458 services with total Medicare billing of $434,696. Data is available for 4 years (2020–2023), covering 92 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Lebanon, TN
- Active Since 07/31/2006
- Last Updated 01/22/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1396751749
Products in Payments
- VRAYLAR (Drug) $433.92
- Ozempic (Drug) $425.28
- TRELEGY ELLIPTA (Drug) $254.73
- UBRELVY (Drug) $167.22
- INSPIRE (Device) $141.33
- RYBELSUS (Drug) $137.99
- Rybelsus (Drug) $126.38
- ENTRESTO (Drug) $123.12
- SHINGRIX (Biological) $111.87
- BREZTRI (Drug) $108.62
- AIRSUPRA (Drug) $102.85
- AUSTEDO (Drug) $102.01
- XIFAXAN (Drug) $97.14
- Cologuard Collection Kit (Device) $93.22
- QULIPTA (Drug) $71.54
- BOOSTRIX (Biological) $60.15
- Livalo (Drug) $56.50
- FREESTYLE LIBRE 2 (Device) $47.71
- Omnia (Device) $46.97
- APTIMA (Device) $43.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lebanon
Dr. Philip Mitchell, Md, MD
Family Medicine — Payments: $28,512
Dr. Roger Mckinney, M.d, M.D
Family Medicine — Payments: $19,969
Samuel Crutcher, M.d, M.D
Family Medicine — Payments: $17,412
Tricia Wright, Md, MD
Family Medicine — Payments: $13,503
Emma Nordstrom, Md, MD
Family Medicine — Payments: $13,128
Justin Wright, Md, MD
Family Medicine — Payments: $12,770